Researchers are making advancements in colorectal cancer care through various methods, including novel biomarker research and the use of patient-derived xenograft models. The integration of artificial intelligence and precision science is also being explored to improve cancer treatment, particularly in the field of gastrointestinal cancer. Additionally, significant funding and partnerships, such as a major grant and a licensing agreement, are being established to support cancer research and development.